RHUMBLINE ADVISERS - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 54 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$249,236
-22.0%
133,287
+4.8%
0.00%
Q2 2023$319,337
+763.1%
127,226
+741.7%
0.00%
Q1 2022$37,000
+8.8%
15,115
+17.9%
0.00%
Q4 2021$34,000
-49.3%
12,823
-4.5%
0.00%
Q3 2021$67,000
-28.0%
13,426
+7.3%
0.00%
Q2 2021$93,00012,5180.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders